Mapping large numbers of results may take a few moments.
Search Results
Showing 201 - 250 of 489 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company GENIE Therapeutics | Activity: Research and Development | Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. | Location Winston-Salem |
| |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hedros Biotechnology | Activity: Research and Development | Company Description Hedros Biotechnology has developed a software platform to create custom bacteriophage cocktails, with the goal to eradicate acute hepatopancreatic necrosis disease (AHPND) in shrimp. | Location Raleigh |
| |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh |
| |
Company HemoSonics LLC | Activity: Research and Development | Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. | Location Durham |
| |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh |
| |
Company Hoofprint Biome | Activity: Research and Development | Company Description Hoofprint Biome engineers probiotics to eliminate methane from livestock while improving production performance. | Location Raleigh |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Ideal Health Biotechnology LLC | Activity: Research and Development | Company Description Ideal Health Biotechnology researches and develops dietary supplements made from plant-based compounds, including products derived from grape seed extract and algae for digestion, eye disease and diabetes. | Location Kannapolis |
| |
Company Iluma Alliance | Activity: Research and Development | Company Description Iluma Alliance develops, manufactures and markets nutritional and health ingredients for animals, as well as nutritional ingredients for humans. This location is the innovation labs and conducts research on feed additives for animal nutrition and health. | Location Durham |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem |
| |
Company Immunolight LLC | Activity: Research and Development | Company Description Immunolight develops energy modulating technology to activate immunotherapeutics for the treatment of cancer. | Location Oak Island |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |
| |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh |
| |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Indigo Agriculture | Activity: Research and Development | Company Description Indigo Agriculture utilizes plant microbes to improve crop health and productivity, with a portfolio focused on cotton, wheat, corn, soybeans and rice. | Location Research Triangle Park |
| |
Company IndiOmics LLC | Activity: Research and Development | Company Description Indiomics uses machine learning and protein biomarker expression levels to identify connections between human cells and common chemical exposures. | Location Clayton |
| |
Company IngateyGen LLC | Activity: Research and Development | Company Description IngateyGen is an early stage Ag Biotech company using CRISPR genome editing technology to develop an allergen reduced peanut, a peanut with modified oil profile and an ultra high protein peanut for improved safety and nutritional value to consumers. | Location Research Triangle Park |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park |
| |
Company Innatrix Inc. | Activity: Research and Development | Company Description Innatrix is developing eco-friendly alternative means of crop protection, utilizing a patented peptide & RNAi delivery technology platform. | Location Research Triangle Park |
| |
Company Innovasive Environmental LLC | Activity: Research and Development | Company Description Innovasive Environmental develops environmentally-friendly, species-specific herbicides based on a species’ genome. | Location Black Mountain |
| |
Company Innovative Neurophysiology Inc. | Activity: Research and Development | Company Description Innovative Neurophysiology designs and develops advanced tools, equipment and methodology for neuroscience research. | Location Durham |
| |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham |
| |
Company Integrated Precision Metabolomics | Activity: Research and Development | Company Description Integrated Precision Metabolomics is developing a new type of mass spectrometer instrumentation and related software that will enable easier metabolomics analysis by end users. | Location Chapel Hill |
| |
Company Interventional AnalgesiX Inc. | Activity: Research and Development | Company Description Interventional AnalgesiX is developing non-addictive analgesics for chronic pain. | Location Durham |
| |
Company Invaio Sciences Inc. | Activity: Research and Development | Company Description Invaio Sciences is developing sustainable methods for managing plant pests and pathogens. As a multi-platform technology company, Invaio utilizes natural systems to solve pressing agriculture, nutrition, & environmental challenges. | Location Durham |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Isolere Bio Inc. | Activity: Research and Development | Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. | Location Durham |
| |
Company Isosceles Pharmaceuticals Inc. | Activity: Research and Development | Company Description Isosceles Pharmaceuticals is a specialty pharmaceutical company developing novel therapeutics for pain indications. | Location Wilmington |
| |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville |
| |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham |
| |
Company Jaguar Gene Therapy LLC (Process Sciences Lab) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's process sciences lab is located in Cary. | Location Cary |
| |
Company Jellatech Inc. | Activity: Research and Development | Company Description Jellatech develops technologies to produce animal-free collagen and gelatin by growing cells in a bioreactor. | Location Raleigh |
| |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham |